• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Development and verification of the PAM50-based Prosigna breast cancer gene signature assay 
    •   QMRO Home
    • Wolfson Institute of Preventive Medicine
    • Centre for Cancer Prevention
    • Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
    •   QMRO Home
    • Wolfson Institute of Preventive Medicine
    • Centre for Cancer Prevention
    • Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Development and verification of the PAM50-based Prosigna breast cancer gene signature assay

    View/Open
    Wallden Development and verification of the PAM50-based Prosigna breast cancer gene signature assay 2015 Published.pdf (1.773Mb)
    Volume
    8
    DOI
    10.1186/s12920-015-0129-6
    Journal
    BMC MEDICAL GENOMICS
    ISSN
    1755-8794
    Metadata
    Show full item record
    Authors
    Wallden, B; Storhoff, J; Nielsen, T; Dowidar, N; Schaper, C; Ferree, S; Liu, S; Leung, S; Geiss, G; Snider, J
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/12235
    Collections
    • Centre for Cancer Prevention [860]
    Licence information
    CC-BY
    Copyright statements
    © 2015 Wallden et al
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.